Valsartan and Rosuvastatin Tablets 10/80 mg

Adult dose

For essential hypertension, the recommended starting dose of valsartan is 80 mg orally once daily, and in cases where blood pressure control is poor, the dose may be increased up to a maximum of 320 mg per day. For heart failure, the starting dose is 40 mg orally twice a day, which may be increased up to 80 mg or 160 mg per single dose. To reduce the risk of mortality after myocardial infarction, the starting dose is 20 mg administered orally twice daily, gradually increasing the dosage.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age, so it should not be administered.

This medication may cause serious harm to the fetus, especially after the second trimester, so it should be discontinued immediately upon confirmation of pregnancy. Women of childbearing potential should use appropriate contraceptive methods, and it is safe for pregnant or breastfeeding women to avoid this medication. This medication should not be administered to patients with severe liver or kidney dysfunction, liver cirrhosis, bile duct obstruction, or certain muscular diseases. Caution is needed for the elderly, patients with hyperkalemia, and those with liver disorders, and regular liver and kidney function tests are recommended. Because this medication lowers blood pressure, symptoms of hypotension or dizziness may occur, so caution should be exercised during driving or operating machinery. Additionally, if symptoms such as muscle pain or weakness occur, consulting a doctor immediately is necessary, and in severe cases, discontinuation of the medication may be needed. This medication may interact with other antihypertensive agents, diuretics, potassium supplements, and certain antibiotics, so it is essential to inform your doctor of any other medications being taken. In cases of overdose, severe hypotension or altered consciousness may occur, and immediate medical attention is required; blood dialysis is not effective. This medication has not been established for safety and efficacy in children and adolescents, so it should not be used. When storing, keep it out of reach of children and do not transfer it to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis, urinary retention

Mild side effects

Dyspepsia, nausea, dizziness, headache, conjunctival hemorrhage, constipation, asthenia, chest pain, facial swelling, peripheral edema, nasopharyngitis, urinary tract infection, bruising, increased serum liver transaminase (AST, ALT) levels, increased serum creatinine phosphokinase, increased serum potassium levels, increased gamma-glutamyl transferase, musculoskeletal stiffness, limb pain, paresthesia, anxiety, upper respiratory tract infection, pharyngitis, tonsillitis, spinal canal stenosis, insomnia

This medication is sensitive to light, so it should be stored in light-resistant containers. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance

Pink round film-coated tablets

Package unit

30 tablets per box [(10 tablets/PTP) * 3]